EMAIL THIS PAGE TO A FRIEND

PloS one

Comprehensive In Vitro Toxicity Testing of a Panel of Representative Oxide Nanomaterials: First Steps towards an Intelligent Testing Strategy.


PMID 25996496

Abstract

Nanomaterials (NMs) display many unique and useful physico-chemical properties. However, reliable approaches are needed for risk assessment of NMs. The present study was performed in the FP7-MARINA project, with the objective to identify and evaluate in vitro test methods for toxicity assessment in order to facilitate the development of an intelligent testing strategy (ITS). Six representative oxide NMs provided by the EC-JRC Nanomaterials Repository were tested in nine laboratories. The in vitro toxicity of NMs was evaluated in 12 cellular models representing 6 different target organs/systems (immune system, respiratory system, gastrointestinal system, reproductive organs, kidney and embryonic tissues). The toxicity assessment was conducted using 10 different assays for cytotoxicity, embryotoxicity, epithelial integrity, cytokine secretion and oxidative stress. Thorough physico-chemical characterization was performed for all tested NMs. Commercially relevant NMs with different physico-chemical properties were selected: two TiO2 NMs with different surface chemistry - hydrophilic (NM-103) and hydrophobic (NM-104), two forms of ZnO - uncoated (NM-110) and coated with triethoxycapryl silane (NM-111) and two SiO2 NMs produced by two different manufacturing techniques - precipitated (NM-200) and pyrogenic (NM-203). Cell specific toxicity effects of all NMs were observed; macrophages were the most sensitive cell type after short-term exposures (24-72h) (ZnO>SiO2>TiO2). Longer term exposure (7 to 21 days) significantly affected the cell barrier integrity in the presence of ZnO, but not TiO2 and SiO2, while the embryonic stem cell test (EST) classified the TiO2 NMs as potentially 'weak-embryotoxic' and ZnO and SiO2 NMs as 'non-embryotoxic'. A hazard ranking could be established for the representative NMs tested (ZnO NM-110 > ZnO NM-111 > SiO2 NM-203 > SiO2 NM-200 > TiO2 NM-104 > TiO2 NM-103). This ranking was different in the case of embryonic tissues, for which TiO2 displayed higher toxicity compared with ZnO and SiO2. Importantly, the in vitro methodology applied could identify cell- and NM-specific responses, with a low variability observed between different test assays. Overall, this testing approach, based on a battery of cellular systems and test assays, complemented by an exhaustive physico-chemical characterization of NMs, could be deployed for the development of an ITS suitable for risk assessment of NMs. This study also provides a rich source of data for modeling of NM effects.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

N8285
β-Nicotinamide adenine dinucleotide, pkg of 10 mg (per vial)
C21H27N7O14P2
N8410
β-Nicotinamide adenine dinucleotide, pkg of 20 mg (per vial)
C21H27N7O14P2
N8535
β-Nicotinamide adenine dinucleotide, pkg of 50 mg (per vial)
C21H27N7O14P2
N7004
β-Nicotinamide adenine dinucleotide hydrate, ≥96.5% (HPLC), ≥96.5% (spectrophotometric assay), from yeast
C21H27N7O14P2 · xH2O
N6522
β-Nicotinamide adenine dinucleotide hydrate, ≥98%, BioUltra, from yeast
C21H27N7O14P2 · xH2O
N1636
β-Nicotinamide adenine dinucleotide hydrate, purified by column chromatography, ≥99%
C21H27N7O14P2 · xH2O
N3014
β-Nicotinamide adenine dinucleotide hydrate, cell culture tested, ≥96.5% (HPLC), ≥96.5% (spectrophotometric assay), from yeast
C21H27N7O14P2 · xH2O
N7381
β-Nicotinamide adenine dinucleotide hydrate, Grade AA-1, ≥95% (HPLC)
C21H27N7O14P2 · xH2O
N1511
β-Nicotinamide adenine dinucleotide hydrate, ≥99%
C21H27N7O14P2 · xH2O
43410
β-Nicotinamide adenine dinucleotide hydrate, ≥95% (HPLC)
C21H27N7O14P2 · xH2O
N7132
β-Nicotinamide adenine dinucleotide lithium salt from Saccharomyces cerevisiae, ≥95%
C21H26LiN7O14P2
L4391 Lipopolysaccharides from Escherichia coli O111:B4, γ-irradiated, BioXtra, suitable for cell culture
P13207
Phenazine, 98%
C12H8N2
T4184 Thrombopoietin from mouse, recombinant, expressed in NSO cells, lyophilized powder, suitable for cell culture, >97% (SDS-PAGE)